Charles Schwab Investment Management Inc Uni Qure N.V. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Uni Qure N.V. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 269,980 shares of QURE stock, worth $3.98 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
269,980
Previous 277,275
2.63%
Holding current value
$3.98 Million
Previous $1.37 Million
248.98%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding QURE
# of Institutions
169Shares Held
42.8MCall Options Held
2.61MPut Options Held
582K-
Eco R1 Capital, LLC San Francisco, CA3.4MShares$50.2 Million2.81% of portfolio
-
Vestal Point Capital, LP New York, NY3.03MShares$44.6 Million3.17% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.45MShares$36.2 Million2.18% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.18MShares$32.1 Million0.56% of portfolio
-
Franklin Resources Inc San Mateo, CA1.99MShares$29.3 Million0.01% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $690M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...